Exchange: NYSEMkt·Updated 11:19 PM EDT
AEON logo

AEON AEON Biopharma Inc. - Ordinary Shares - Class A

$0.2941
$0.0018
(0.61%)
Overnight
Prev Close $0.2959
Mkt Cap$15.67M
Vol507,909.00

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
79

Extremely Bullish Sentiment

How do you feel about AEON?

Advertisement|Remove ads.